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Objectives 
For patients with endometrial cancer at 
increased risk of perioperative morbidity, 
primary radiation therapy is an effective 
alternative treatment option. However, 
there has been no consensus on 
radiation technique and little data on 
outcomes. Our aim was to identify factors 
which determine patient selection for 
primary radiation, investigate treatment 
efficacy of radiation compared to surgical 
management of endometrial cancer and 
to evaluate different radiation modalities 
including external beam radiation 
therapy alone or with a boost of either 
high dose rate brachytherapy or 
intensity-modulated radiation therapy for 
differences in toxicities, recurrence-free 
interval, cancer-specific survival and 
overall survival. 
Methods 
The cancer registry database at our 
institution was searched for all patients 
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diagnosed with endometrial cancer from 
2004-2014. We identified 78 patients 
treated with primary radiation and 
randomly selected a comparator group of 
136 patients treated with surgery up 
front. These patients were analyzed for 
demographic, clinicopathologic, and 
outcome variables. The radiation 
patients were subgrouped according to 
radiation technique: external beam 
radiation alone or with either high dose 
rate brachytherapy or intensity-
modulated radiation therapy. Survival 
probabilities were estimated and plotted 
using the Kaplan-Meier method. Cox 
regression models were used to evaluate 
the effect of clinicopathologic and 
treatment characteristics on outcomes 
separately for each treatment type. 
Results 
Primary patient characteristic cited as the 
reason for undergoing primary radiation 
over standard of care included medical 
comorbidities (48.7%) and morbid 
obesity (43.6%). Treatment toxicities 
were similar between therapy groups. 
The 5-year recurrence-free interval was 
65% for radiation vs 85% for surgery. The 
5-year cancer-specific survival was 
similar (radiation 91%, surgery 98%). 
However, there was a substantial 
difference in the 5-year overall survival 
between radiation and surgery, 26% vs 
92% respectively. Between radiation 
subgroups, we found no significant 
difference in primary reason for 
undergoing radiation, toxicity from 
treatment, recurrence-free interval, 
cancer-specific survival or overall 
survival. Age and BMI were significantly 
associated with overall survival in the RT 
group (p<0.01, p<0.01) in multivariate 
analysis. 
Conclusions 
There are several different radiation 
techniques utilized for inoperable 
endometrial cancer. Our study 
demonstrates that toxicities of radiation 
are comparable to surgery, recurrence 
and cancer specific survival are similar, 
but the overall survival in patients 
receiving primary radiation therapy is 
much worse due to high rates of death 
from intercurrent disease. Furthermore, 
intensity-modulated radiation therapy 
seems to be a reasonable alternative to 
brachytherapy, however boosting the 
total radiation dose via the addition of 
brachytherapy or intensity-modulated 
radiation therapy may not improve 
recurrence or survival. 
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